Manon Ragonnet-Cronin1,2, Christina Hayford3, Richard D'Aquila3, Fangchao Ma4, Cheryl Ward4, Nanette Benbow3, Joel O Wertheim1. 1. Department of Medicine, University of California San Diego, San Diego, CA. 2. Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom. 3. Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL; and. 4. Illinois Department of Public Health, Chicago, IL.
Abstract
BACKGROUND: HIV intervention activities directed toward both those most likely to transmit and their HIV-negative partners have the potential to substantially disrupt HIV transmission. Using HIV sequence data to construct molecular transmission clusters can reveal individuals whose viruses are connected. The utility of various cluster prioritization schemes measuring cluster growth have been demonstrated using surveillance data in New York City and across the United States, by the Centers for Disease Control and Prevention (CDC). METHODS: We examined clustering and cluster growth prioritization schemes using Illinois HIV sequence data that include cases from Chicago, a large urban center with high HIV prevalence, to compare their ability to predict future cluster growth. RESULTS: We found that past cluster growth was a far better predictor of future cluster growth than cluster membership alone but found no substantive difference between the schemes used by CDC and the relative cluster growth scheme previously used in New York City (NYC). Focusing on individuals selected simultaneously by both the CDC and the NYC schemes did not provide additional improvements. CONCLUSION: Growth-based prioritization schemes can easily be automated in HIV surveillance tools and can be used by health departments to identify and respond to clusters where HIV transmission may be actively occurring.
BACKGROUND: HIV intervention activities directed toward both those most likely to transmit and their HIV-negative partners have the potential to substantially disrupt HIV transmission. Using HIV sequence data to construct molecular transmission clusters can reveal individuals whose viruses are connected. The utility of various cluster prioritization schemes measuring cluster growth have been demonstrated using surveillance data in New York City and across the United States, by the Centers for Disease Control and Prevention (CDC). METHODS: We examined clustering and cluster growth prioritization schemes using Illinois HIV sequence data that include cases from Chicago, a large urban center with high HIV prevalence, to compare their ability to predict future cluster growth. RESULTS: We found that past cluster growth was a far better predictor of future cluster growth than cluster membership alone but found no substantive difference between the schemes used by CDC and the relative cluster growth scheme previously used in New York City (NYC). Focusing on individuals selected simultaneously by both the CDC and the NYC schemes did not provide additional improvements. CONCLUSION: Growth-based prioritization schemes can easily be automated in HIV surveillance tools and can be used by health departments to identify and respond to clusters where HIV transmission may be actively occurring.
Authors: Stéphane Le Vu; Oliver Ratmann; Valerie Delpech; Alison E Brown; O Noel Gill; Anna Tostevin; Christophe Fraser; Erik M Volz Journal: Epidemics Date: 2017-10-20 Impact factor: 4.396
Authors: Sharoda Dasgupta; Anne Marie France; Mary-Grace Brandt; Jennifer Reuer; Tianchi Zhang; Nivedha Panneer; Angela L Hernandez; Alexandra M Oster Journal: AIDS Res Hum Retroviruses Date: 2018-12-20 Impact factor: 2.205
Authors: Joel O Wertheim; Ben Murrell; Sanjay R Mehta; Lisa A Forgione; Sergei L Kosakovsky Pond; Davey M Smith; Lucia V Torian Journal: J Infect Dis Date: 2018-11-05 Impact factor: 5.226
Authors: Susan J Little; Sergei L Kosakovsky Pond; Christy M Anderson; Jason A Young; Joel O Wertheim; Sanjay R Mehta; Susanne May; Davey M Smith Journal: PLoS One Date: 2014-06-05 Impact factor: 3.240
Authors: Art F Y Poon; Réka Gustafson; Patricia Daly; Laura Zerr; S Ellen Demlow; Jason Wong; Conan K Woods; Robert S Hogg; Mel Krajden; David Moore; Perry Kendall; Julio S G Montaner; P Richard Harrigan Journal: Lancet HIV Date: 2016-04-07 Impact factor: 12.767